These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 18037105)
21. Osteomalacia induced by a phosphaturic mesenchymal tumor secreting fibroblast growth factor 23. Nagae K; Uchi H; Ito T; Moroi Y; Oda Y; Furue M Eur J Dermatol; 2015 Apr; 25(2):199-200. PubMed ID: 25788099 [No Abstract] [Full Text] [Related]
22. Emphasis should be placed on the diagnosis and therapy of tumor induced osteomalacia. Wang XL; Mu YM Chin Med J (Engl); 2011 Jan; 124(2):163-5. PubMed ID: 21362358 [No Abstract] [Full Text] [Related]
23. The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases. Feng J; Jiang Y; Wang O; Li M; Xing X; Huo L; Li F; Yu W; Zhong DR; Jin J; Liu Y; Qi F; Lv W; Zhou L; Meng XW; Xia WB Endocr J; 2017 Jul; 64(7):675-683. PubMed ID: 28450684 [TBL] [Abstract][Full Text] [Related]
27. [Oncogenic osteomalacia: the role of the phosphatonins. Diagnostic usefulness of the Fibroblast Growth Factor 23 measurement in one patient]. Dupond JL; Magy N; Mahammedi M; Prie D; Gil H; Meaux-Ruault N; Kantelip B Rev Med Interne; 2005 Mar; 26(3):238-41. PubMed ID: 15777586 [TBL] [Abstract][Full Text] [Related]
28. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. Fukumoto S; Yamashita T N Engl J Med; 2003 Jul; 349(5):505-6; author reply 505-6. PubMed ID: 12892105 [No Abstract] [Full Text] [Related]
29. Hypophosphatemia: A Practical Guide to Evaluation and Management. Tebben PJ Endocr Pract; 2022 Oct; 28(10):1091-1099. PubMed ID: 35940468 [TBL] [Abstract][Full Text] [Related]
30. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia. Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220 [TBL] [Abstract][Full Text] [Related]